Overview

The 22nd Annual International Lung Cancer Congress^® will distill the latest data on targeted agents, immunotherapy, surgery, and radiation oncology to provide you with current and practical information on the management of patients with lung cancer. As in previous years, we will also preview novel agents and strategies with the potential to shape the future of lung cancer therapy. Cutting-edge lectures and extended panel discussions, along with multidisciplinary tumor boards and interactive question-and-answer sessions, will provide a unique opportunity for participants to engage with leading international and national experts as they share their perspectives and personal experiences surrounding clinical challenges and ongoing controversies in lung cancer management.

Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer are also invited to attend.

Hot Topics for 2021

• Adjuvant EGFR-targeted therapy
• Choosing firstline immunotherapy-based regimens
• Targeted agents and the expanding array of oncogenic drivers
• Telemedicine and incorporating technology in the practice of oncology